Pandion Therapeutics Inc (PAND)

Ex-FBI Trainee Gets 15 Months for Trading on Girlfriend’s Info

The pandemic forced millions of people to share working spaces with their partners or spouses while shut in their homes. For some, such as former FBI trainee Seth Markin, the close proximity led to temptation.

INVESTIGATION ALERT: Halper Sadeh LLP Investigates CTB, FFG, PAND, SVBI; Shareholders Are Encouraged to Contact the Firm

BREAKING NEWS ALERT: Halper Sadeh LLP Investigates CTB, FFG, PAND, SVBI, FPRX; Shareholders are Encouraged to Contact the Firm

SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and PAND Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

INVESTIGATION ALERT: Halper Sadeh LLP Investigates CMD, COHR, PRSP, CUB, PAND; Shareholders are Encouraged to Contact the Firm

SHAREHOLDER ALERT: WeissLaw LLP Reminds SVBI, FRPX, PAND and VKIN Shareholders About Its Ongoing Investigations

INVESTIGATION ALERT: Halper Sadeh LLP Investigates WIFI, PRAH, PAND, CTB; Shareholders Are Encouraged to Contact the Firm

SHAREHOLDER ALERT: WeissLaw LLP Reminds PAND, VKIN, CLGX, and VGAC Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Buyout Investigation

ALERT: Halper Sadeh LLP Investigates WIFI, PRAH, PAND, CTB; Shareholders are Encouraged to Contact the Firm

Lifshitz Law Firm, P.C. Announces Investigation of APEX, CTB, GT, FRTA, PAND, PRAH, ICLR, PBCT and MBT

PANDION THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pandion Therapeutics, Inc. - PAND

INVESTIGATION ALERT: Halper Sadeh LLP Investigates PAND, PRAH, FFG, CTB; Shareholders Are Encouraged to Contact the Firm

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Pandion Therapeutics, Inc. - PAND

Are These The Top Biotech Stocks To Buy In March? 4 Names To Consider

Will biotech stocks show momentum like how they did last year? Let’s find out.

Moore Kuehn Encourages SFTW, PRAH, RTP, and PAND Investors to Contact Law Firm

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

Why Pandion Therapeutics Stock Blasted Sky-High on Thursday

You'd vault into the air too if a big-name pharmaceutical paid a high premium for your stock.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Pandion Therapeutics, Inc.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Pandion Therapeutics, Inc. Buyout

PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm

Pandion Therapeutics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Pandion Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PAND

PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today

Pandion Therapeutics (PAND) stock is soaring higher on Thursday after announcing that Merck (MRK) plans to acquire the biotechnology company.

Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout

Pandion Therapeutics stock blasted to a record high Thursday on Merck's plan to buy the IPO stock for $1.85 billion. Pandion completed its IPO in July.